Dabur Sues Patanjali Over Toothpaste Trade Dress

New Delhi:  Dabur India on Wednesday moved the Delhi High Court alleging that Patanjali Ayurveda’s Dant Kanti Red infringed upon the trade dress of its Red toothpaste with pan flavour.

The court asked Patanjali Ayurved if it could modify the visual appearance of the product. The court posted the matter for further hearing on January 31.

The HC was hearing a suit filed by Dabur seeking a permanent injunction against Patanjali Ayurved, the parent company of Patanjali Foods, for the similarity in trade dress. Dabur said it did not have any grievance over the earlier packaging of Patanjali Ayurved in respect of similar products.

However, it is now becoming difficult to maintain a distinction between the two products due to the similarity in their trade dress, it said. Patanjali Ayurved launched its Dant Kanti Red toothpaste with pan flavour in December.

Related Posts

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Cancer cure must not be hostage to Big Pharma

Cancer cure must not be hostage to Big Pharma

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid